AAX Biotech to attend Antibody Engineering and Therapeutics Europe 2025

We are excited to share that Daniel X Johannson, CSO of AAX Biotech, will be presenting a poster at Antibody Engineering & Therapeutics Europe from June 10 – 12!

This conference, organized in collaboration with The Antibody Society, brings together leading minds in antibody research and development. If you are attending the conference and want to chat about Seqitope®, for high-resolution and high throughput epitope mapping and Opti-mAb®, for stabilizing scFv antibody fragments, feel free to reach out!

Looking forward to connecting with fellow scientists, innovators, and partners driving the next generation of antibody therapeutics.